共 18 条
[4]
人乳头瘤病毒16型病毒样颗粒的制备及其免疫原性研究[J]. 魏旻希,李少伟,黄博,沈文通,苏永在,张春华,顾颖,杜海莲,张军,夏宁邵.病毒学报. 2009(04)
[6]
中国妇女人乳头瘤病毒感染和子宫颈癌的流行病学研究现状及其疫苗预防前景[J]. 乔友林.中华流行病学杂志. 2007(10)
[7]
Adolescent and young adult HPV vaccination in Australia: Achievements and challenges[J] . Suzanne M. Garland,S. Rachel Skinner,Julia M.L. Brotherton.Preventive Medicine . 2011
[9]
Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women[J] . N. De Carvalho,J. Teixeira,C.M. Roteli-Martins,P. Naud,P. De Borba,T. Zahaf,N. Sanchez,A. Schuind.Vaccine . 2010 (38)
[10]
Clinical Trial and Post-Licensure Safety Profile of a Prophylactic Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine[J] . Stan L. Block,Darron R. Brown,Archana Chatterjee,Michael A. Gold,Heather L. Sings,Anne Meibohm,Adrian Dana,Richard M. Haupt,Eliav Barr,Gretchen M. Tamms,Haiping Zhou,Keith S. Reisinger.The Pediatric Infectious Disease Journal . 2010 (2)